Allergan (AGN), Valeant and Pershing Capital Agree On Meeting
September 16, 2014 at 09:01 AM EDT
Shares of Allergan Inc. (AGN) were up +1.44 or +0.85 percent to $170.00 per share in premarket trading this morning, after the company announced late yesterday that an agreement had been struck between Valeant Pharmaceuticals (VRX) and Bill Ackman’s Pershing Square Capital to proceed with a special shareholder’s meeting. Allergan stock closed down -0.69 or Read the full article... Read the rest of Allergan (AGN), Valeant and Pershing Capital Agree On Meeting at InvestorGuide.com .